Hyoungyoung Kim

Hyoungyoung Kim

Auto-generated profile, based on publicly available information

Hyoungyoung Kim

Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Seminars in Arthritis and Rheumatism
Verified
Journal Article
Closed access
HKHyoungyoung Kim
Hyoungyoung Kim
SCSoo-Kyung Cho
Soo-Kyung Cho
JKJin Wook Kim
Jin Wook Kim
SJSun-Young Jung
Sun-Young Jung
EJEun Jin Jang
Eun Jin Jang
YSYoon-Kyoung Sung
Yoon-Kyoung Sung

1 January 2019 in Journal of Korean Medical Science
Verified
Journal Article
Open access
SCSoo-Kyung Cho
Soo-Kyung Cho
HKHyoungyoung Kim
Hyoungyoung Kim
JMJisun Myung
Jisun Myung
ENEunwoo Nam
Eunwoo Nam
SJSun-Young Jung
Sun-Young Jung
YSYoon-Kyoung Sung
Yoon-Kyoung Sung
This study aimed to estimate the incidence and prevalence of idiopathic inflammatory myopathies (IIM) and associated comorbidities in Korea from 2006 to 2015. IIM between 2004 to 2015 were identified using the Korean National Health Insurance Service medical claim database. The case definition required more than one visit based on diagnostic codes including juvenile dermatomyositis (JDM), dermatomyositis (DM), or polymyositis (PM) and registration in the Individual Copayment Beneficiaries Program (ICBP) for rare and intractable diseases. IIM patients with a disease-free period of 24 months before the index date were defined as incident cases. The Elixhauser comorbidity score was calculated. Using the base case definition, 1,150 prevalent patients with IIM (117 JDM, 521 DM, 512 PM) were recorded in 2006 and 2,210 (130 JDM, 1,101 DM, 869 PM) in 2015. The prevalence was estimated at 2.3-4.0 (0.9-1.2 for JDM, 1.2-2.7 for DM, 1.4-2.1 for PM)/100,000 person-year (PY). We identified 218 incident cases of IIM in 2006 (18 JDM, 98 DM, 102 PM) and 191 cases (7 JDM, 83 DM, 101 PM) in 2015. The incidence was estimated at 2.9-5.2 (0.7-1.9 for JDM, 1.8-4.0 for DM, 1.6-3.0 for PM)/1,000,000 PY. The mean age (± standard deviation) of prevalent patients with IIM was 51.2 (± 16.9) years, and the percentage of women was 72.1%. More than two-thirds of patients (70.7%) had more than two comorbidities. Twenty percent of patients had interstitial lung diseases. In Korea, the incidence and prevalence of IIM were 2.9-5.2/1,000,000 PY and 2.3-4.0/100,000 PY, respectively.

25 August 2020 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
JKJuyeon Kang
Juyeon Kang
HKHyoungyoung Kim
Hyoungyoung Kim
JKJinwook Kim
Jinwook Kim
SCSeongmi Choi
Seongmi Choi
SJSun-Young Jung
Sun-Young Jung
YSYoon-Kyoung Sung
Yoon-Kyoung Sung

1 January 2020 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
HKHyoungyoung Kim
Hyoungyoung Kim
SCSoo-Kyung Cho
Soo-Kyung Cho
HKHye Won Kim
Hye Won Kim
JHJungyong Han
Jungyong Han
YKYu Jeong Kim
Yu Jeong Kim
YSYoon-Kyoung Sung
Yoon-Kyoung Sung
Kim H, et al. J Korean Med Sci. 2020 Oct;35(45):e369. https://doi.org/10.3346/jkms.2020.35.e369

14 May 2019 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
HKHyoungyoung Kim
Hyoungyoung Kim
SCSoo-Kyung Cho
Soo-Kyung Cho
JLJiyoung Lee
Jiyoung Lee
SBSuk-Chul Bae
Suk-Chul Bae
YSYoon-Kyoung Sung
Yoon-Kyoung Sung

30 November 2020 in Journal of Bone Metabolism
Verified
Journal Article
Open access
PDF file
TLTae-Han Lee
Tae-Han Lee
YSYeo-Jin Song
Yeo-Jin Song
HKHyoungyoung Kim
Hyoungyoung Kim
YSYoon-Kyoung Sung
Yoon-Kyoung Sung
SCSoo-Kyung Cho
Soo-Kyung Cho
In this study, we aimed to evaluate and compare the treatment indication for patients with glucocorticoid-induced osteoporosis (GIOP) in various clinical practice guidelines. We searched for potentially relevant studies conducted from January 2000 to March 2020 using online databases, including PubMed, Ovid-EMBASE, Guidelines International Network, National Institute for Health and Clinical Excellence, KoreaMed, KMbase, and KoMGI. We reviewed and analyzed the guidelines that included recommendations on GIOP and fulfilled the inclusion criteria. A total of 94 articles were selected based on review of the title and abstract; 14 guidelines were assessed upon reviewing the full text. The bone mineral density score for therapeutic intervention of GIOP in postmenopausal women was presented in 7 guidelines, among which 3 guidelines set a T-score of −2.5 or lower and the other 4 guidelines proposed a less stringent cut-off point of −1.5 or lower. Among the 10 guidelines published since 2012 after the emergence of the fracture risk assessment tool (FRAX), 6 guidelines included FRAX in their criteria for defining intervention thresholds. However, they were further divided into fixed-probability (n=3) and age-dependent (n=3) thresholds based on the country. Recently developed guidelines use FRAX as the criterion for establishing the treatment of patients with GIOP. However, these intervention thresholds need to be adapted for each country.